About this trial
The purpose of the study is to refine, finalize, implement, and evaluate a multi-level intervention aimed at increasing enrollment of Black and Hispanic patients to National Cancer Institute (NCI)-sponsored therapeutic clinic trials at Moffitt Cancer Center.
Eligibility criteria
Qualifiers
Community residents: Community residents may engage with various intervention components deployed in the intervention priority zones.
Community Physicians: may engage with various intervention components deployed in the intervention priority zones if they 1) practice medicine in one of the geographic priority zones.
Cancer Center Physicians: may engage with various intervention components if they 1) practice medicine at Moffitt.
Clinical Research Coordinators (CRC): may engage with various intervention components if they 1) work as a CRC at Moffitt and 2) coordinate/pre-screen patients for at least 1 therapeutic clinical trial at Moffitt.
Disqualifiers
Community residents, Community Physicians, Cancer Center Physicians, Clinical Research Coordinators, and Moffitt patients who do not meet the inclusion criteria.
Trial design
Treatments tested in this trial
- Continuing Medical Education Events (CME)
- Trial Connect Portal
- Clinical Trial Newsletters
- Implicit Bias Training
- Recruitment Dashboard
- Portfolio Profiler
- Eligibility Calculator
- Clinical Trial Education Sessions (Community Residents Only)
- ACT WONDER²S Phone-line/Email (Community Residents and Moffitt Patients)
- New Patient Information (Moffitt Patients Only)
- No Intervention
Treatment groups
6
Treatment groupsSee each treatment group below.
Sponsors and collaborators
H. Lee Moffitt Cancer Center and Research Institute
Lead sponsor
National Cancer Institute (NCI)
Collaborator